BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12975556)

  • 1. Cyclosporine A in the treatment of a patient with immune thrombocytopenia accompanied by myelodysplastic syndrome and nephrotic syndrome.
    Park SJ; Han CW; Lee JH; Eom HS; Lee SH; Jeong DC; Lim JH
    Acta Haematol; 2003; 110(1):36-40. PubMed ID: 12975556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children.
    Gesundheit B; Cividalli G; Freeman A; Yatziv S; Koren G; Baruchel S
    Eur J Haematol; 2001 May; 66(5):347-51. PubMed ID: 11422416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders.
    Funato K; Kuriyama Y; Uchida Y; Suzuki A; Miyazawa K; Ohyashiki K
    Intern Med; 2001 Oct; 40(10):1041-4. PubMed ID: 11688831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
    Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
    Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].
    Murase K; Matsunaga T; Takimoto R; Takahira N; Fujimi A; Takeuchi N; Terui T; Niitsu Y
    Rinsho Ketsueki; 2004 May; 45(5):383-6. PubMed ID: 15199747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].
    Matsuura T; Hiramoto N; Iwasa T; Shoji M; Ohashi K
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1327-34. PubMed ID: 24288970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticoid-sensitive nephrotic syndrome in children with myelodysplastic syndromes].
    Bogdanović R; Kuzmanović M; Marković-Lipkovski J; Ognjanović M; Mićić D; Stanković I; Stajić N; Nikolić V; Bunjevacki G
    Srp Arh Celok Lek; 2002; 130(9-10):323-8. PubMed ID: 12577674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report.
    Furukawa H; Nomura J; Kobayashi M; Abe S; Takeda T; Oka Y; Shirota Y; Kodera T; Okitsu Y; Takahashi S; Murakami K; Kameoka J
    Tohoku J Exp Med; 2023 Jan; 259(2):113-119. PubMed ID: 36450481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular involvement in myelodysplastic syndromes.
    Bogdanović R; Kuzmanović M; Marković-Lipkovski J; Ognjanović M; Mićić D; Stanković I; Stajić N; Nikolić V; Bunjevacki G
    Pediatr Nephrol; 2001 Dec; 16(12):1053-7. PubMed ID: 11793099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease.
    Treliński J; Chojnowski K; Kurenko-Deptuch M; Kasznicki M; Bernatowska E; Robak T
    Ann Hematol; 2005 Nov; 84(12):835-6. PubMed ID: 16078034
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial splenic embolization in myelodysplastic syndrome associated with immune thrombocytopenia.
    Ozdogu H; Boga C; Oğuzkurt L; Kizilkilic E
    J Thromb Thrombolysis; 2004 Dec; 18(3):213-6. PubMed ID: 15815885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
    Salomon R; Gagnadoux MF; Niaudet P
    Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
    Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
    Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
    Cataland SR; Jin M; Lin S; Kraut EH; George JN; Wu HM
    Am J Hematol; 2008 Dec; 83(12):911-5. PubMed ID: 18821711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment with cyclosporine for myelodysplastic syndrome with erythroid hypoplasia following rheumatoid arthritis].
    Tsuji T; Yamasaki H; Tsuda H
    Rinsho Ketsueki; 2010 Jun; 51(6):427-32. PubMed ID: 20622490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis.
    Katsumata Y; Suzuki T; Kuwana M; Hattori Y; Akizuki S; Sugiura H; Matsuoka Y
    Arthritis Rheum; 2003 Jun; 48(6):1647-51. PubMed ID: 12794833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.